• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Options Trading Now Available on Three Tradr ETFs: QBTX, TEMT and APPX

    5/21/25 12:57:00 PM ET
    $APP
    $QBTS
    $TEM
    Computer Software: Programming Data Processing
    Technology
    EDP Services
    Technology
    Get the next $APP alert in real time by email

    Surging demand for 2X Leveraged Daily ETFs tied to D-Wave Quantum, Tempus AI & AppLovin now met with expanded trading flexibility

    NEW YORK, May 21, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today announced that options trading is now available on its newest three leveraged ETFs: Tradr 2X Long QBTS Daily ETF (Cboe: QBTX), Tradr 2X Long TEM Daily ETF (Cboe: TEMT), and Tradr 2X Long APP Daily ETF (NASDAQ:APPX).

    The three ETFs, all first-to-market products, have quickly gained traction among traders seeking 200% daily long exposure to highly followed, liquid single names involved in emerging technology: D-Wave Quantum (NYSE:QBTS), Tempus AI (NASDAQ:TEM), and AppLovin (NASDAQ:APP). Launched on April 24, 2025, QBTX has rapidly become one of the fastest-growing ETFs of the year, buoyed by the recent price surge in D-Wave Quantum shares. The fund now has $12.5 million in assets and has notched an average daily trading volume of 403,000 shares since D-Wave reported 1Q25 earnings on May 8. Listing the same day as QBTX, APPX has also witnessed impressive asset growth with AUM topping $13.5 million. Meanwhile, TEMT, which more recently debuted on May 12, 2025, has already attracted $11.5 million in assets.

    "The strong early demand for QBTX, TEMT and APPX highlights how traders are increasingly on the hunt for tools that let them express high conviction views in robust-growth, high-volatility stories like quantum computing, AI-driven medicine and mobile advertising," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "Now, with options available on QBTX, TEMT and APPX, investors have even more flexibility to manage risk, hedge exposure or build directional positions aligned with their short-term market views."

    For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit www.tradretfs.com.

    About Tradr ETFs

    Tradr ETFs are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.

    IMPORTANT RISK INFORMATION

    Tradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.

    Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.

    Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.

    The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.

    ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective.

    ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.

    Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting www.tradretfs.com. The Prospectus should be read carefully before investing.

    Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000684

    (PRNewsfoto/Tradr ETFs)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/options-trading-now-available-on-three-tradr-etfs-qbtx-temt-and-appx-302462195.html

    SOURCE TRADR ETFs

    Get the next $APP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $APP
    $QBTS
    $TEM

    CompanyDatePrice TargetRatingAnalyst
    Tempus AI Inc.
    $TEM
    4/21/2025$60.00Buy
    BTIG Research
    Applovin Corporation
    $APP
    4/10/2025$350.00Equal-Weight → Overweight
    Morgan Stanley
    Applovin Corporation
    $APP
    3/28/2025$385.00Outperform
    FBN Securities
    Tempus AI Inc.
    $TEM
    2/25/2025$50.00 → $55.00Overweight → Neutral
    Analyst
    Tempus AI Inc.
    $TEM
    2/12/2025Outperform → Mkt Perform
    William Blair
    Tempus AI Inc.
    $TEM
    2/5/2025$58.00 → $74.00Buy
    TD Cowen
    Applovin Corporation
    $APP
    1/10/2025$375.00Buy
    The Benchmark Company
    Tempus AI Inc.
    $TEM
    12/13/2024$60.00Outperform
    Wolfe Research
    More analyst ratings

    $APP
    $QBTS
    $TEM
    Financials

    Live finance-specific insights

    See more
    • D-Wave Reports First Quarter 2025 Results

      Record Quarterly Revenue of $15 Million - Up Over 500% Year over Year Record Quarterly GAAP Gross Profit of $13.9 Million Record Quarter End Cash Position of $304.3 Million D-Wave Quantum Inc., (NYSE:QBTS) ("D-Wave" or the "Company") a leader in commercial quantum computing systems, software, and services, today announced financial results for its first quarter ended March 31, 2025. "The first quarter of 2025 was arguably the most significant in D-Wave's history, especially in terms of our unique ability to deliver quantum value today to our customers and the scientific community," said Dr. Alan Baratz, CEO of D-Wave. "We recognized revenue on our first Advantage™ system sale to a major

      5/8/25 7:00:00 AM ET
      $QBTS
      EDP Services
      Technology
    • Tempus Reports First Quarter 2025 Results

      Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended March 31, 2025. Revenue increased 75.4% year-over-year to $255.7 million in the first quarter of 2025 Quarterly gross profit increased 99.8% year-over-year, reaching $155.2 million with continued gross margin improvement in both Genomics and Data and services Announced multi-year, strategic collaborations with AstraZeneca and Pathos to work together to build the largest multimodal foundation model in oncology, resulting in additional $200.0 million in data licensing and model development fees over the next

      5/6/25 4:01:00 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Tempus to Report First Quarter 2025 Financial Results on May 6

      Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the first quarter of 2025 on Tuesday, May 6, 2025. The company will hold the earnings conference call at 4:30 p.m. ET. The company's quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following: Conference ID: 4680302 Domestic Dial-in Number: (800) 715-9871 International Dial-in Number: (646) 307

      4/24/25 8:30:00 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology

    $APP
    $QBTS
    $TEM
    SEC Filings

    See more
    • SEC Form 144 filed by D-Wave Quantum Inc.

      144 - D-Wave Quantum Inc. (0001907982) (Subject)

      6/12/25 4:16:45 PM ET
      $QBTS
      EDP Services
      Technology
    • SEC Form 144 filed by D-Wave Quantum Inc.

      144 - D-Wave Quantum Inc. (0001907982) (Subject)

      6/12/25 4:16:43 PM ET
      $QBTS
      EDP Services
      Technology
    • SEC Form 144 filed by Applovin Corporation

      144 - AppLovin Corp (0001751008) (Subject)

      6/11/25 4:53:18 PM ET
      $APP
      Computer Software: Programming Data Processing
      Technology

    $APP
    $QBTS
    $TEM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Tempus Ai, Inc. exercised 9,218,800 in-the-money shares at a strike of $2.00 and bought $17,745,000 worth of shares (3,500,000 units at $5.07) (SEC Form 4)

      4 - Tempus AI, Inc. (0001717115) (Reporting)

      8/20/24 4:17:55 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology

    $APP
    $QBTS
    $TEM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by D-Wave Quantum Inc.

      SC 13G/A - D-Wave Quantum Inc. (0001907982) (Subject)

      11/15/24 7:37:26 AM ET
      $QBTS
      EDP Services
      Technology
    • Amendment: SEC Form SC 13G/A filed by Applovin Corporation

      SC 13G/A - AppLovin Corp (0001751008) (Subject)

      11/13/24 7:11:04 PM ET
      $APP
      Computer Software: Programming Data Processing
      Technology
    • SEC Form SC 13G filed by Tempus AI Inc.

      SC 13G - Tempus AI, Inc. (0001717115) (Subject)

      11/12/24 5:00:02 PM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology

    $APP
    $QBTS
    $TEM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BTIG Research initiated coverage on Tempus AI with a new price target

      BTIG Research initiated coverage of Tempus AI with a rating of Buy and set a new price target of $60.00

      4/21/25 8:39:11 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • AppLovin upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded AppLovin from Equal-Weight to Overweight and set a new price target of $350.00

      4/10/25 8:26:55 AM ET
      $APP
      Computer Software: Programming Data Processing
      Technology
    • FBN Securities initiated coverage on AppLovin with a new price target

      FBN Securities initiated coverage of AppLovin with a rating of Outperform and set a new price target of $385.00

      3/28/25 8:18:31 AM ET
      $APP
      Computer Software: Programming Data Processing
      Technology

    $APP
    $QBTS
    $TEM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Tempus Announces Collaboration with Northwestern University's Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer's Disease Research

      Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with The Abrams Research Center on Neurogenomics at Northwestern University Feinberg School of Medicine. This multi-year collaboration aims to harness AI for rapid discovery and innovation in Alzheimer's disease research. The collaboration leverages Tempus' AI-powered data analytics platform, Lens, to analyze and restructure the Center's repository of genomic data. Together, the Center and Tempus teams will work to uncover genomic patterns that have the potential to advance the understanding of Alzheimer's disease, investigate the ge

      6/12/25 8:30:00 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers

      Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced xM for treatment response monitoring (TRM), a liquid biopsy assay intended to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in advanced solid tumors. xM for TRM is the newest addition to Tempus' growing portfolio of sensitive assays for monitoring molecular response and minimal residual disease (MRD). It is currently available for research use only, with clinical availability expected later this year. In 2023, an estimated 56.55% of patients with advanced or metastatic cancers were eligible for ICIs, with a corresponding est

      6/2/25 8:30:00 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology
    • Introducing Tempus One in the EHR with Integrated Guidelines

      The AI-enabled clinical assistant is available to query patient data across the EHR as well as build custom agents to maximize workflow Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of Tempus One—its generative AI clinical assistant—with direct integration into electronic health record (EHR) systems. By integrating AI at every point of the clinical care process, the expanded capabilities of Tempus One offer physicians in oncology and beyond more support in treatment decisions. Tempus One is uniquely positioned to offer these new features given the company's depth and scale of EHR

      6/1/25 8:30:00 AM ET
      $TEM
      Computer Software: Programming Data Processing
      Technology

    $APP
    $QBTS
    $TEM
    Leadership Updates

    Live Leadership Updates

    See more
    • AppLovin Appoints Maynard Webb to Its Board of Directors

      AppLovin Corporation (NASDAQ:APP) ("AppLovin" or the "Company"), the leading marketing platform, today announced the appointment of Maynard Webb, founder of Webb Investment Network (WIN), to AppLovin's Board of Directors, as an independent director and member of the Audit Committee and Nominating and Corporate Governance Committee of the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250409518219/en/Maynard Webb, founder of Webb Investment Network, joins AppLovin's board of directors. "We are thrilled to welcome Maynard Webb to the AppLovin board. I've had the privilege of knowing Maynard for 13 years, since his early inve

      4/9/25 5:00:00 PM ET
      $APP
      Computer Software: Programming Data Processing
      Technology
    • D-Wave Names Sharon Holt to Board of Directors

      Board appointment further supports company's aggressive go-to-market efforts amid accelerating adoption of its annealing quantum computing solutions    D-Wave Quantum Inc. (NYSE:QBTS), a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, today announced the appointment of Sharon Holt to its board of directors. The appointment comes on the heels of the October 2024 additions of John DiLullo and Rohit Ghai to the D-Wave board, as the company continues to usher in the era of commercial quantum computing. Holt is a seasoned technology executive, investor, and board director with extensive global industry experience in

      11/25/24 7:00:00 AM ET
      $QBTS
      EDP Services
      Technology
    • AppLovin Corporation to Join the Nasdaq-100 Index® Beginning November 18, 2024

      NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that AppLovin Corporation (NASDAQ:APP), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX) and the Nasdaq-100 Equal Weighted™ Index (NASDAQ:NDXE) prior to market open on Monday, November 18, 2024. AppLovin Corporation will replace Dollar Tree, Inc. (NASDAQ:DLTR) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index. Dollar Tree, Inc. will also be removed from the Nasdaq-100 Ex-Tech Sector™ Index (NASDAQ:NDXX), the Nasdaq-100 ESG™ Index (NASDAQ:NDXESG), the Nasdaq-100 Sustainable ESG Select™ Index (NASDAQ:NDXSES) , the Nasdaq-100 ex Top 30™ Index (NASDAQ:NDX), and the Nasdaq-100 ex T

      11/8/24 8:00:00 PM ET
      $APP
      $DLTR
      $NDAQ
      Computer Software: Programming Data Processing
      Technology
      Department/Specialty Retail Stores
      Consumer Discretionary

    $APP
    $QBTS
    $TEM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Nielsen Kirstjen was granted 14,260 shares, increasing direct ownership by 8% to 191,317 units (SEC Form 4)

      4 - D-Wave Quantum Inc. (0001907982) (Issuer)

      6/12/25 8:48:01 PM ET
      $QBTS
      EDP Services
      Technology
    • Director Biscay Roger was granted 14,260 shares, increasing direct ownership by 13% to 120,886 units (SEC Form 4)

      4 - D-Wave Quantum Inc. (0001907982) (Issuer)

      6/12/25 8:47:51 PM ET
      $QBTS
      EDP Services
      Technology
    • Director Ghai Rohit was granted 14,260 shares, increasing direct ownership by 16% to 101,295 units (SEC Form 4)

      4 - D-Wave Quantum Inc. (0001907982) (Issuer)

      6/12/25 8:47:40 PM ET
      $QBTS
      EDP Services
      Technology